Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein

Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein

Monkeypox (now Mpox), a zoonotic disease caused by the monkeypox virus (MPXV) is an emerging threat to global health. In the time span of only six months, from May to October 2022, the number of MPXV cases breached 80,000 and many of the outbreaks occurred in locations that had never previously repo...

Full description

Bibliographic Details
Main Authors: Carolyn N. Ashley, Emmanuel Broni, Chanyah M. Wood, Tunmise Okuneye, Mary-Pearl T. Ojukwu, Qunfeng Dong, Carla Gallagher, Whelton A. Miller
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
monkeypox virus
orthopoxviruses
tecovirimat
molecular docking
molecular dynamics simulation
ADMET
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1351737/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2024.1351737/full

Similar Items